Close Menu

microarrays

NEW YORK (GenomeWeb) — Startup Adarza Biosystems said last week that it has raised $6.8 million in a Series A financing round to support the commercialization of its first multiplex protein detection array and readout system by next year and to continue developing additional multiplex assays in c

NEW YORK (GenomeWeb) – EpiCypher, a Chapel Hill, NC-based bioscience company, is preparing a new microarray for epigenetics research.

Affymetrix has been awarded

NEW YORK (GenomeWeb) – Rubicon Genomics today said that it has signed distribution deals with new partners covering parts of Europe, North Africa, and Asia, further expanding the market reach for its DNA library preparation kits for arrays and Illumina next-generation sequencing platforms.

NEW YORK (GenomeWeb) – In Nature Genetics, Spanish researchers reported on the recombination events contributing to Legionella pneumophila outbreaks in Spain over more than a decade.

NEW YORK (GenomeWeb) – Molecular diagnostics firm AutoGenomics has refiled for an initial public offering, less than one year after it pulled earlier plans to go public.

NEW YORK (GenomeWeb) – The Institute for Global Food Security, MBio Diagnostics, and Scienion today announced they will combine their technologies to create tools to monitor marine toxins.

NEW YORK (GenomeWeb) – Mimetas, a developer of 3D disease- and tissue-modelling technologies, today said that it has raised $5.2 million in a private financing round to further develop its organ-on-a-chip technology platform.

NEW YORK (GenomeWeb) — Twistnostics this month was awarded $212,371 from the National Cancer Institute to support the second year of its project to develop an assay for detecting cancer mutations in circulating DNA in body fluids such as blood and urine.

Pages

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.